Considering a switch from IVIg to SCIg for primary immunodeficiency? Explore differences in responsibility, side effects, costs, and how each impacts quality of life.

CERRITOS, Calif.--(BUSINESS WIRE)--KabaFusion, a leading provider of specialty acute and chronic home infusion therapies, today announced it has acquired the home infusion assets of Lincare, a ...

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers ALYGLO™, manufactured by GC Biopharma, for the treatment of patients with primary humoral immunodeficiency (PI) in adults. This ...

New information about how to monitor medications given at home has been provided by the results of new research. Many autoimmune neuromuscular disorders, such as Myasthenia Gravis, myositis, and CIDP, ...

ARLINGTON, Texas, December 02, 2025--(BUSINESS WIRE)--AOM Infusion ("AOM"), a leading provider of specialty infusion and pharmacy services for chronic and complex conditions, has been selected by ...

Connie Sullivan, president and CEO of the National Home Infusion Association (NHIA), discusses why at-home infusion is beneficial to patients and why so many patients reported feeling satisfied with ...

HOUSTON, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Memorial Hermann Health System – a nonprofit health system committed to creating healthier Houston communities – has established a services agreement with ...

NEW YORK (Reuters Health) - Intravenous immunoglobulin (IVIg) may offer some relief for patients with sensorimotor neuropathy or nonataxic sensory neuropathy associated with primary Sjögren's syndrome ...